BD (Becton, Dickinson and Company) , a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a ...

China's first domestically produced and independently developed anti-PD-1 monoclonal antibody. Toripalimab has been approved in over 35 countries and regions including China, the US, and Europe.

and MIAMI - NAYA Biosciences (NASDAQ: NAYA), a $3.9 million market cap portfolio company specializing in oncology, autoimmune diseases, and women's health, announced today its plan to introduce a ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to ...

Ltd. has exercised its exclusive option to acquire global development, manufacturing, and commercialization rights for an antibody-drug conjugate (ADC) from DualityBio, a collaborator of Nona ...

Dec 31 (Reuters) - Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, draft papers showed on Tuesday, at the fag end of what has ...

"We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over ...

“We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over age 60 ...

Analysis of surface molecules on CD3+ T cells was performed using the following monoclonal antibodies: APC-H7-conjugated anti-human CD3 (BD Biosciences, Heidelberg, Germany), anti-human CD4-VioBlue, ...

The antibodies used are listed in Supplementary Table 1. Cells were analyzed or sorted with a FACSAria IIu cell sorter (BD Biosciences) equipped with 488 nm (50 mW), 561 nm (100 mW), 638 nm (140 mW), ...